HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study

Authors

Institutions

Publication Details

Journal
Radiation Oncology
Published
2026-05-29
DOI
https://doi.org/10.1186/s13014-026-02856-3
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study

Heinz‐Peter Schlemmer, Florian Stieler, Jens Fleckenstein, Victor Siefert et al.
Radiation Oncology
Nutrition and Health in Aging
article

HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study

Heinz‐Peter Schlemmer, Florian Stieler, Jens Fleckenstein, Victor Siefert, F Giordano, Marvin Willam, Michael Ehmann, Constantin Dreher, Miriam Eckl, Daniel Buergy, Ralf Schmidt, Alicia S. Bicu, Stefan O. Schoenberg, Bettina Beuthien-Baumann, Judit Boda-Heggemann, Matthias F. Froelich, Joana V. Bettenhausen
article en

Abstract

No abstract available for this paper.
Radiation OncologyVol. 21(1)
University of Mannheim (DE), German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), University Medical Centre Mannheim (DE), Guided Therapeutics (United States) (US)
Deutsches Krebsforschungszentrum
Openalex Percentile: Top 6%
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.